Daniel J. Haraf to Triazines
This is a "connection" page, showing publications Daniel J. Haraf has written about Triazines.
Connection Strength
0.072
-
Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer. Int J Radiat Oncol Biol Phys. 2007 Mar 01; 67(3):678-84.
Score: 0.072